Travis Alan Gerke

Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.

McKay RR, Gold T, Zarif JC, Chowdhury-Paulino IM, Friedant A, Gerke T, Grant M, Hawthorne K, Heath E, Huang FW, Jackson MD, Mahal B, Ogbeide O, Paich K, Ragin C, Rencsok EM, Simmons S, Yates C, Vinson J, Kantoff PW, George DJ, Mucci LA.

JCO Glob Oncol. 2021 Apr. 7:495-505. PMID: 33835826

Circulating lipids and glioma risk: results from the UK Biobank, Nurses' Health Study, and Health Professionals Follow-Up Study.

Cote DJ, Smith-Warner SA, Creed JH, Furtado J, Gerke T, Wang M, Kim Y, Stampfer MJ, Egan KM.

Cancer Causes Control. 2021 Apr. 32(4):347-355. PMID: 33484419

Accessible Pipeline for Translational Research Using TCGA: Examples of Relating Gene Mechanism to Disease-Specific Outcomes.

Berglund AE, Putney RM, Creed JH, Aden-Buie G, Gerke TA, Rounbehler RJ.

Methods Mol Biol. 2021. 2194:127-142. PMID: 32926365

Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.

Yamoah K, Awasthi S, Mahal BA, Zhao SG, Grass GD, Berglund A, Abraham-Miranda J, Gerke T, Rounbehler RJ, Davicioni E, Liu Y, Park J, Cleveland JL, Pow-Sang JM, Fernandez D, Torres-Roca J, Karnes RJ, Schaeffer E, Freedland SJ, Spratt DE, Den RB, Rebbeck TR, Feng F.

Eur Urol. 2020 Dec 07. PMID: 33303244

TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.

Yamoah K, Lal P, Awasthi S, Naghavi AO, Rounbehler RJ, Gerke T, Berglund AE, Pow-Sang JM, Schaeffer EM, Dhillon J, Park JY, Rebbeck TR.

Prostate. 2021 Feb. 81(2):109-117. PMID: 33141952

Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell-Level PI3K Pathway Activation.

Stopsack KH, Huang Y, Tyekucheva S, Gerke TA, Bango C, Elfandy H, Bowden M, Penney KL, Roberts TM, Parmigiani G, Kantoff PW, Mucci LA, Loda M.

Clin Cancer Res. 2020 Nov 15. 26(22):5903-5913. PMID: 32913135

Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations.

Hernandez-Prera JC, Valderrabano P, Creed JH, de la Iglesia JV, Slebos RJC, Centeno BA, Tarasova V, Hallanger-Johnson J, Veloski C, Otto KJ, Wenig BM, Yoder SJ, Lam CA, Park DS, Anderson AR, Raghunand N, Berglund A, Caudell J, Gerke TA, Chung CH.

Thyroid. 2021 01. 31(1):36-49. PMID: 32689909

Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer.

Stopsack KH, Gerke T, Zareba P, Pettersson A, Chowdhury D, Ebot EM, Flavin R, Finn S, Kantoff PW, Stampfer MJ, Loda M, Fiorentino M, Mucci LA.

Carcinogenesis. 2020 07 14. 41(7):904-908. PMID: 32556091

Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen.

Fankhauser CD, Penney KL, Gonzalez-Feliciano AG, Clarke NW, Hermanns T, Stopsack KH, Fiorentino M, Loda M, Mahal B, Gerke TA, Preston MA, Mucci LA.

Eur Urol. 2020 10. 78(4):637-639. PMID: 32624279

Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study.

Khan S, Caldwell J, Wilson KM, Gonzalez-Feliciano AG, Peisch S, Pernar CH, Graff RE, Giovannucci EL, Mucci LA, Gerke TA, Markt SC.

Cancer Epidemiol Biomarkers Prev. 2020 06. 29(6):1229-1236. PMID: 32277004